AI Governance in Life Sciences: Over Half of Leaders Taking Action Now

The Responsible AI in Life Sciences (RAIL) Report 2026 has unveiled that 64% of leaders in the life sciences sector are actively working towards establishing a robust AI governance framework. This initiative signifies a pivotal shift in how pharmaceutical, biotech, and medical device companies are approaching the incorporation of AI technologies across their commercial, medical, and patient-facing operations.

The research, conducted by ACTO, highlights a pressing need among life sciences organizations to scale agentic AI responsibly while prioritizing trust and safety. Among the surveyed leaders, a staggering 81% identified a validated AI as critical, while 79% considered ethical implications as paramount, followed by 75% prioritizing safety. This feedback underscores the importance of developing AI applications that not only enhance productivity but also ensure patient welfare.

The Trust Factor: A Barrier to Scaling AI

Despite the acknowledgment of AI's potential, trust remains one of the most significant hurdles to its widespread adoption in the industry. An alarming 58% of leaders expressed concerns regarding the lack of clear standards governing responsible AI usage. The survey results indicated that while 68% of leaders are currently involved in AI projects, 54% feel uneasy about how AI is being utilized within their organizations. Such a disconnect between eagerness to adopt AI technologies and apprehension regarding their governance suggests that establishing trust will be crucial for scaling operations effectively.

Moreover, leaders ranked regulatory, legal, or compliance hesitations as the primary internal barriers to AI scaling, overshadowing concerns about technical readiness. A notable observation was that 21% of those surveyed viewed governance as the most neglected aspect of AI implementation.

Setting Up AI Governance

In response to these challenges, leaders are beginning to outline comprehensive governance models. Governance is being defined as an ongoing operational framework that extends beyond initial approvals, encapsulating continual oversight and responsiveness. Essential components of this governance model include assigning designated business owners, establishing clear escalation pathways, and creating standard operating procedures (SOPs) that dictate AI deployment.

However, accountability for AI actions still remains contentious. When asked who should bear ultimate responsibility for the activities of an AI agent, the opinions were divided between end users, legal and compliance teams, AI vendors, and IT departments. This ambiguity could lead to lapses in accountability if not properly addressed.

AI Adoption: Skills for the Future

The journey towards integrating AI efficiently does not come without its challenges, particularly regarding workforce adaptation. Roundtable discussions led to the conclusion that the most critical skills humans must retain include judgment, human connection, and strategic thinking. As AI continues to permeate daily operations, redefining roles and responsibilities becomes imperative to ensure that a human touch remains a critical component of patient interaction.

The Introduction of the RAIL Score

To facilitate industry-wide collaboration on AI trust metrics, the report introduces the RAIL Score, a standard that measures agentic AI systems across six pillars: governance, security, testing and certification, human centricity, value creation, and orchestration. Each of these components will be evaluated and rated to offer companies a benchmark for responsible AI usage.

This standard aims to boost confidence among stakeholders by focusing on evidence-based assessments rather than solely on vendor claims. According to Parth Khanna, co-founder and CEO of ACTO, the industry has reached a critical juncture where discussions are no longer centered around whether to adopt agentic AI, but rather about which systems can be reliably scaled with proper oversight.

Conclusion

The findings of the RAIL Report 2026 ultimately reflect the life sciences sector's desire to not only harness the power of AI but also to do so in a manner that preserves trust and prioritizes ethical considerations. As the landscape evolves, leaders emphasize that establishing solid governance mechanisms will be foundational to achieving the long-term benefits expected from AI technologies. With a growing focus on responsible AI practices, it becomes evident that trust not only facilitates innovation but also ensures that patient safety remains at the forefront of the industry.

For further insights and resources from the RAIL Report 2026, visit acto.com/RAIL.